Results 61 to 70 of about 19,441,916 (250)

Biological effects of low level laser therapy.

open access: yesJournal of lasers in medical sciences, 2014
The use of low level laser to reduce pain, inflammation and edema, to promote wound, deeper tissues and nerves healing, and to prevent tissue damage has been known for almost forty years since the invention of lasers. This review will cover some of the proposed cellular mechanisms responsible for the effect of visible light on mammalian cells ...
Farivar, Shirin   +2 more
openaire   +2 more sources

Low-level laser therapy as a treatment for chronic pain [PDF]

open access: yesFrontiers in Physiology, 2014
Chronic pain is defined as pain that persists for greater than 12 weeks (Task-Force, 1994) and currently affects roughly 30% of the population in the United States (Johannes et al., 2010). The most common method for managing chronic pain has traditionally been pharmacological (Nalamachu, 2013).
Kingsley, J. Derek   +2 more
openaire   +3 more sources

Paclitaxel induces NM2‐dependent cellular contraction through GEF‐H1 dissociation from microtubules and RhoA/ROCK activation in cancer cells

open access: yesMolecular Oncology, EarlyView.
Taxanes are widely used chemotherapeutics whose effects on cellular mechanics remain poorly understood. We show that paclitaxel induces rapid cellular contraction by promoting GEF‐H1 dissociation from microtubules and non‐muscle myosin II activation through RhoA/ROCK.
Gloria Asensio‐Juárez   +5 more
wiley   +1 more source

Low-level Laser Therapy in Knee Osteoarthritis: A Prospective Analytical Study

open access: yesJournal of Clinical Orthopaedics
Background/Aims: Osteoarthritis (OA) is the second common rheumatologic disorder and the most prevalent joint disease in India, affecting 20–40% of the population.
V Sriram, Nrupatunga K K, L Sachin Patel
doaj   +1 more source

In dogs does low level laser therapy reduce healing time?

open access: yesVeterinary Evidence, 2020
PICO question In dogs with a surgical or open wound does low level laser therapy increase the speed of wound contracture and reduce the healing time?   Clinical bottom line Category of research question Treatment The number and type of
Emma Jane Suiter
doaj   +1 more source

An experimental study of low-level laser therapy in rat Achilles tendon injury [PDF]

open access: yes, 2011
The aim of this controlled animal study was to investigate the effect of low-level laser therapy (LLLT) administered 30 min after injury to the Achilles tendon. The study animals comprised 16 Sprague Dawley male rats divided in two groups.
Iversen, Vegard Vereide   +13 more
core   +1 more source

p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer: a novel cancer‐relevant paralog interplay

open access: yesMolecular Oncology, EarlyView.
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault   +12 more
wiley   +1 more source

Case series of low-level laser therapy for minor ulceration: Diverse outcomes related to predisposing factors

open access: yesScientific Dental Journal, 2023
Background: There are many strategies to alleviate the pain and suffering associated with oral mucosal ulcers. Low-level laser therapy (LLLT) has recently been widely used as a treatment for oral lesions because of its modalities in promoting ulcer ...
Ratna Kumala Indrastiti   +3 more
doaj   +1 more source

Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells

open access: yesMolecular Oncology, EarlyView.
We established the avian chorioallantoic membrane (CAM) assay as a scalable in vivo model for studying circulating tumor cells (CTCs). Human gastrointestinal tumors spontaneously released genetically validated CTCs that were detected across multiple platforms, demonstrating that the CAM model provides an accessible tool for investigating early cancer ...
Dennis Roth   +17 more
wiley   +1 more source

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy